Last week's tentative recovery in Applied Materials has been erased — the stock fell another 7.8% Tuesday to close at $476.46, extending its monthly loss to 24% and reopening the question of where the floor is.
The prior note flagged a stabilisation at $536.25 and noted that options traders hadn't yet stood down from their defensive positioning. That caution proved well-founded. The put/call ratio has now climbed to 1.30 — a fresh 52-week high, running roughly 1.4 standard deviations above its 20-day average of 1.19. The directional arc is stark: the PCR spent most of June in the 0.93–1.00 range, climbed steadily through July, and has now reached its highest level of the past year. Options traders are more defensively positioned today than at any point since this data series began. The lending market, by contrast, tells a completely different story. Borrow availability is effectively unlimited — with 763 million shares available against roughly 16 million short, the pool is about as loose as it gets. Cost to borrow remains negligible at 0.30%. Short interest itself has fallen sharply, down 14% on the week and 23% on the month to just 2.0% of free float. The short book has largely capitulated; the pressure on the stock is coming from long-side exits, not short-side additions.
The Street's bullish consensus is increasingly difficult to reconcile with the price action. Analysts spent late June and early July in a coordinated target-raising exercise — UBS lifted to $705, Needham went to $740, TD Cowen moved to $700, and Susquehanna set the high-water mark at $900. Morgan Stanley, the most cautious of the group, still raised its Equal-Weight target to $647. With the stock now at $476, the gap between the average Street target and the current price has blown out to levels that imply either a dramatic re-rating opportunity or a set of stale assumptions. The bull case rests on AMAT's exposure to AI-driven capex at TSMC, Intel, and Samsung, and on the gate-all-around technology cycle where Applied Materials holds strong process positions. Bears point to China market headwinds — domestic Chinese fabs are accelerating local alternatives — and to a forward PE that, even after the selloff, remains near 32x, with EV/EBITDA around 27x. The 30-day compression in the PE multiple has been severe, down roughly 17 turns, but valuation remains stretched relative to near-term earnings growth, which ranks only in the 28th percentile on a forward year-over-year basis.
The peer group offers no comfort. Lam Research fell 7.5% Tuesday and is down 16% on the week. KLA Corporation dropped 6.2% Tuesday and is off 12% for the week. Smaller names took a harder beating — Ultra Clean Holdings fell 10.9% Tuesday and is down 26% on the week, while Ichor Holdings shed 13% Tuesday alone and is off nearly 29% for the week. ACM Research and MKS Instruments both fell around 9–10% on the day. The breadth of the decline rules out an AMAT-specific story; this is a sector-wide repricing, with the smaller, more levered names absorbing the most damage.
One insider data point is worth noting without overstating. CEO Gary Dickerson sold approximately $50 million of stock across late June and early June trades, with the largest block — nearly 50,000 shares — transacted on June 29 at $700. Those sales were executed as the stock was near its peak. The trades carry significance scores of 3, reflecting normal planned-selling cadence rather than distressed exit, but the timing means Dickerson captured prices roughly 47% above where the stock closed Tuesday.
With the August 13 earnings date now two weeks out, the question sharpens: the options market is pricing maximum defensiveness, analysts are holding targets that look like a different era, and the short book has already been wrung out. Whether Tuesday's session marks another pause or the beginning of a sustained reversal depends on what management says about the China exposure trajectory and whether AI-related equipment orders remain on the timelines analysts have modelled.
See the live data behind this article on ORTEX.
Open AMAT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.